Ananda Scientific announces US Food and Drug Administration approval…


(BUSINESS WIRE)– announced today Ananda Scientific a research-focused pharmaceutical and biotechnology company, announced that the US Food and Drug Administration (FDA) has approved an application for a new experimental drug for use in a clinical trial evaluating a drug’s efficacy. Nanthea A1002N5S which is an experimental drug that uses cannabidiol through a technique fluid delivery Ananda company, as a possible treatment for social anxiety disorder or what is known as “social phobia”. Funding will be provided by the National Center for Complementary and Integrative Health (HCCIH – a division of the National Institutes of Health) for the trial, which will be conducted at the Grossman School of Medicine at New York University. ( identification code for this trial: nct05571592)

The principal investigators of this trial are Dr. Naomi Simon, M.D., professor of psychiatry and director of the Anxiety, Stress, and Prolonged Grief Program at New York University Grossman School of Medicine, and Dr. Esther Blessing, M.D., assistant professor at Grossman College of Medicine. at New York University. This trial will be studied based on a double-blind test and comparison using actual medication Nanthea A1002N5S versus placebo compared with placebo over a 21-day treatment period, with primary outcome measures defined as change in the Trier social stress test (TSST) for anxiety and effect on neuroimaging biomarkers.

And she said Dr. Simon in this context: “We are very pleased to move forward with this important study to develop new evidence-based therapies for the treatment of social anxiety disorder, a painful and undertreated condition.”

Dr. Blessing said, “It’s exciting to move forward with clinical trials that build on our promising pre-clinical results of cannabidiol as a treatment for anxiety disorders.”

And he said Dr. Sohail R. Zaidi, CEO, Ananda Corporation : ‘We are very pleased to be working again with Dr. Simon and Dr. Blessing on this important trial that could impact the lives of so many people. We look forward to making further progress in Aqar applications Nanthea A1002N5S Our trial where there is a significant unmet medical need.

About ‘Ananda Scientific’

Ananda is a research-focused biopharmaceutical company that pioneers high-quality clinical studies evaluating therapeutic indications in areas such as post-traumatic stress disorder, neuropathic pain, anxiety, and opioid use disorder (Mount Sinai University and UCLA ). The company relies on patented delivery technologies (licensed by Litropic Delivery Systems Ltd. of Jerusalem, Israel) to make cannabis and other plant-derived compounds bioavailable, water-soluble and with a fixed shelf life, and is focused on producing effective food and pharmaceutical products and high quality.

You can view the original copy of the press release on Business at the following link:

The original language text of this statement is the official, approved version. As for the translation, it is provided for assistance only, and reference must be made to the original language text, which represents the only version with legal effect.


Legal disclaimer: The Middle East and North Africa Financial Services Network provides information “as is” without any representations or warranties…whether express or implied. As this is a disclaimer of our responsibility for the privacy practices or the content of the sites attached within our network, including images and videos. For any inquiries regarding the use and reuse of this information resource please contact the above mentioned article provider.

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.